The fourth issue of the newsletter pertaining to DEEP-2 clinical trial, one of the three studies at the bottom of the DEEP Project (DEferiprone Evaluation in Paediatrics) was published on January 7th, 2015. This Newsletter highlights the main progresses achieved in the study advancement since July 2014 and provides an overview on the status of the participant experimental sites up-to-date as of the 31th of December 2014, from different points of view (regulatory, monitoring, recruitment). It also includes the Frequently Asked Questions (FAQs) emerged, that are all available on the DEEP website. See the newsletter for more data.
The first newsletter of the DEEP-2 clinical trial of the DEEP Project, performing an efficacy/safety test to compare deferiprone with deferasirox, was published on March 31st, 2014. It contains the latest recruitment data as well as the FAQ in order to address some issues raised by the investigators. […]
The first newsletter of the DEEP-1 pharmacokinetic study of the DEEP project was published on December 23rd, 2013. Among other results, the first milestone of the experimental phase, that is the recruitment and study completion of the first 18 patients, has been reached. […]
The first newsletter of the DEEP-3 observational study of the DEEP Project, evaluating the long-term safety of deferiprone in children, was published on October 23rd, 2013. It contains the latest recruitment data as well as useful hints for the data collection. […]
GRiP (Global Research in Paediatrics) is a Network of Excellence which brings together researchers in Paediatric Pharmacology from all over the world. Regular newsletters are published to bring you up to date with the progress of the GRiP Project, whose main objective is to develop research and knowledge in pediatric pharmacology in order to improve the health of children globally. […]